Cargando…

The DDR-related gene signature with cell cycle checkpoint function predicts prognosis, immune activity, and chemoradiotherapy response in lung adenocarcinoma

BACKGROUND: As a DNA surveillance mechanism, cell cycle checkpoint has recently been discovered to be closely associated with lung adenocarcinoma (LUAD) prognosis. It is also an essential link in the process of DNA damage repair (DDR) that confers resistance to radiotherapy. Whether genes that have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Quan, Zhang, Pan, Hu, Huixiao, Huang, Hang, Pan, Dong, Mao, Guangyun, Hu, Burong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288070/ https://www.ncbi.nlm.nih.gov/pubmed/35840978 http://dx.doi.org/10.1186/s12931-022-02110-w

Ejemplares similares

Identification of a Novel Gene Signature with DDR and EMT Difunctionalities for Predicting Prognosis, Immune Activity, and Drug Response in Breast Cancer
por: Zhang, Pan, et al.
Publicado: (2023)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response
por: Yang, Jian, et al.
Publicado: (2022)

The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy
por: Shi, Congqi, et al.
Publicado: (2022)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022)

Construction of a DDR-related signature for predicting of prognosis in metastatic colorectal carcinoma
por: Wei, Maohua, et al.
Publicado: (2023)

Identification of Inflammatory Response-Related Gene Signature Associated With Immune Status and Prognosis of Lung Adenocarcinoma
por: Zou, Weijie, et al.
Publicado: (2021)

Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma
por: Zhang, Hongpan, et al.
Publicado: (2022)

High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma
por: Huo, Yanmiao, et al.
Publicado: (2015)

A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy
por: Zeng, Zhirui, et al.
Publicado: (2022)

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
por: Guo, Dina, et al.
Publicado: (2020)

Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma
por: Ma, Shuai, et al.
Publicado: (2022)

Integrated Analysis of Cell Cycle–Related and Immunity-Related Biomarker Signatures to Improve the Prognosis Prediction of Lung Adenocarcinoma
por: Chen, Fangyu, et al.
Publicado: (2021)

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
por: Yi, Ming, et al.
Publicado: (2021)

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
por: Niu, Yuchun, et al.
Publicado: (2020)

A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance
por: Yang, Longfei, et al.
Publicado: (2023)

The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
por: Elkamhawy, Ahmed, et al.
Publicado: (2021)

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
por: Song, Qian, et al.
Publicado: (2019)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

Development and validation of an immune‐related gene signature for prognosis in Lung adenocarcinoma
por: Guo, Zehuai, et al.
Publicado: (2023)

Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
por: Chen, Pan, et al.
Publicado: (2023)

KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapy
por: Ambrogio, Chiara, et al.
Publicado: (2016)

B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
por: Lin, Anqi, et al.
Publicado: (2022)

An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021)

Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer
por: Terai, Hideki, et al.
Publicado: (2015)

A 2-Gene Signature Related to Interferon-Gamma Predicts Prognosis and Responsiveness to Immune Checkpoint Blockade of Glioma
por: Li, Yongzhe, et al.
Publicado: (2022)

Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis
por: Jiang, Xueping, et al.
Publicado: (2020)

Microenvironment Analysis of Prognosis and Molecular Signature of Immune-Related Genes in Lung Adenocarcinoma
por: Ling, Bo, et al.
Publicado: (2021)

A Novel Immune-Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2022)

Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma
por: Zou, Xiaoli, et al.
Publicado: (2022)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

Identification of a novel cell cycle-related risk signature predicting prognosis in patients with pancreatic adenocarcinoma
por: Xu, Dapeng, et al.
Publicado: (2022)

Immune-DDR crosstalk in pre-leukemia stem cells
por: Wu, Limei, et al.
Publicado: (2017)

Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung
por: Miao, Huikai, et al.
Publicado: (2021)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

An Exosome-Related Long Non-coding RNA (lncRNA)-Based Signature for Prognosis and Therapeutic Interventions in Lung Adenocarcinoma
por: Li, Jinghong, et al.
Publicado: (2023)

Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer
por: Liu, Chao, et al.
Publicado: (2022)

Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy
por: Wang, Qinghua, et al.
Publicado: (2020)

A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy
por: Pan, Runsang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cgjnhmripg4773pnahvl9mgo1l